Abbott (NYSE:ABT) announced today that it received FDA approval for the use of its Patient Controller app on compatible Apple smartphone devices.
The company’s Patient Controller app offers management tools for patients with neurological conditions, such as chronic pain or movement disorders. Now, with the latest approval from the FDA, therapy can be managed directly from a personal smartphone.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,